Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Penicillin V acylase mutant, encoding array, recombinant expression vector, genetically engineered bacterium and application

A technology of acylase mutants and penicillin V, applied in genetic engineering, application, plant gene improvement, etc., can solve the problems of less batches, long reaction time, and low catalytic activity, and achieve enhanced stability and catalytic activity Improved effect

Active Publication Date: 2019-01-08
HUNAN FLAG BIOTECHNOLOGY CO LTD
View PDF6 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, in the process of pilot production of 6-APA by penicillin V acylase enzymatic method in raw material pharmaceutical companies, it is found that due to the shortcomings of wild-type penicillin V acylase, such as low catalytic activity, long reaction time, and few batches, it is seriously restricted. The popularization and application of this enzyme, therefore the development of a new type of penicillin V acylase with high catalytic activity, fast reaction rate and good operational stability has a good market prospect

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Penicillin V acylase mutant, encoding array, recombinant expression vector, genetically engineered bacterium and application
  • Penicillin V acylase mutant, encoding array, recombinant expression vector, genetically engineered bacterium and application
  • Penicillin V acylase mutant, encoding array, recombinant expression vector, genetically engineered bacterium and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0068] Example 1: Construction, expression and purification and immobilization of recombinant protein of wild-type PVA recombinant genetically engineered bacteria

[0069] 1-1 Construction of wild-type PVA prokaryotic expression vector and construction of recombinant genetically engineered bacteria

[0070] The wild-type PVA gene and amino acid sequence used in the present invention are derived from Bacillus sphaericus (GeneBank accession number: P12256.1). The coding gene is optimized through the codon bias of Escherichia coli and the whole gene synthesis is carried out, and the wild-type The penicillin V acylase is named PVA-WT, and its coding gene is named pva-wt. See SEQ ID NO: 1 and SEQ ID NO: 2 for the nucleotide sequence and amino acid sequence.

[0071] refer to figure 1 , the wild-type PVA coding gene pva-wt synthesized by the whole gene and the prokaryotic expression vector pET30a(+) were subjected to EcoR I and Xho I double enzyme digestion respectively, and after ...

Embodiment 2

[0084] Embodiment 2: the preparation of high activity PVA mutant

[0085] 2-1 Construction of PVA mutant library

[0086] In order to improve the activity of wild-type PVA, the inventors used the recombinant expression vector pET-pva-wt as a DNA template, wherein the primers were T7 universal primers (SEQ ID NO: 9 and 10), and constructed a random mutation by error-prone PCR body library, and by adjusting the error-prone PCR reaction system Mg 2+ and Mn 2+ Concentration and concentration of dCTP and dTTP oligonucleotides, so that the base mismatch rate of the mutant library is 5 / 1000, that is, to ensure that a mutant has 1 to 3 amino acid mutations, the specific process of constructing the mutant library is as follows .

[0087] Error-prone PCR reaction system:

[0088]

[0089]

[0090] The error-prone PCR product obtained above was subjected to electrophoresis and gel-cut recovery and purification, and the purified product and the prokaryotic expression vector pET3...

Embodiment 3

[0098] Example 3: Preparation of high substrate concentration tolerance PVA mutants

[0099] Since the activity of wild-type PVA is inhibited by the concentration of penicillin V, in order to obtain a mutant resistant to high concentration of penicillin V and improve its catalytic efficiency, the inventors performed directed evolution mutation again on the basis of the above-mentioned mutant PVA-1, according to the above-mentioned The method in the examples was used to construct a mutant library and perform screening (increasing the penicillin V potassium salt concentration (W / V) from 10% to 20%). About 20,000 clones were screened from the above-mentioned mutant library, and 5 mutants with obvious color changes and higher values ​​than PVA-1 were obtained. After re-screening by shaking flasks, a clone with 2 times higher activity than PVA-1 was obtained, which was named PVA-2. The sequencing results showed that PVA-2 had an amino acid at position 91 relative to wild-type penic...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a penicillin V acylase mutant, an encoding array, a recombinant expression vector, a genetically engineered bacterium and application. Penicillin V acylase derived from Bacillussphaericus is mutated, the specific activity of the obtained mutant PVA-3 is improved by nine times, the immobilization activity is improved to 820U / g from 92U / g, and after being incubated for one hour under a condition of 30% penicillin V sylvite, the mutant has activity residue of 89.1%; the reaction time that the immobilized mutant PVA-3 is adopted to prepare 6-APA (6-Aminopenicillanic Acid) by splitting 25% penicillin V under a condition that the pH value is 6.0 at 25 DEG C is shortened to 60 minutes from 180 minutes, a substrate conversion rate is increased to 99.5% or greater, the activity is not greatly lost after continuous use for 600 times or greater, and good operation stability can be achieved. By adopting the mutated PVA-3, the production cost can be greatly reduced, the production efficiency can be improved, and the mutant is applicable to industrial application.

Description

technical field [0001] The invention belongs to the field of genetic engineering and enzyme engineering, in particular to a penicillin V acylase mutant, coding sequence, recombinant expression vector, genetic engineering bacteria and application. Background technique [0002] Penicillin V is a penicillin antibiotic used in the early stage. It has antibacterial activity against most Gram-positive bacteria, Gram-negative cocci, individual Gram-negative bacilli (such as Haemophilus), spirochetes, and actinomycetes. Strains producing β-lactamases have no antibacterial effect. Currently, penicillin V (PenV) produced by fermentation is mostly used as a raw material for the production of 6-amino-penicillanic acid (6-APA), an intermediate of β-lactam antibiotics. 6-APA is an important intermediate in the synthesis of amoxicillin and ampicillin. [0003] At present, the industrial production of 6-APA of β-lactam antibiotics is mainly obtained by using penicillin G acylase (penicill...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N9/84C12N15/55C12N11/02C12P37/06
CPCC12N9/84C12N11/02C12P37/06C12Y305/01011
Inventor 黄斌赵强周晶辉许岗
Owner HUNAN FLAG BIOTECHNOLOGY CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com